Ownership
Private
Employees
~100
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
IXOPAY General Information
IXOPAY provides an enterprise-grade payment orchestration platform that enables businesses to manage payments across multiple providers with features like tokenization, card lifecycle management, and compliance modules. It serves over 700 customers globally and processes $40 billion in payments annually. The company merged with TokenEx in April 2024 to enhance its data security and vaulting capabilities.
Contact Information
Website
Primary Industry
Biomedical IT and Biomedical Data Platforms
Corporate Office
Vienna, Vienna
Austria
Austria
Drug Pipeline
No pipeline data available
Key Partnerships
Paysafe, Paydoo, Vyne, Fraudio, Payaut, Fraugster
IXOPAY Funding
No funding data available
To view IXOPAY's complete valuation and funding history, request access »
Gosset